We are live on ! Find out more
CYTXW

Cytori Therapeutics Inc Warrant
CYTXW

Delisted

CYTXW was delisted on the 14th of December, 2018.

Back to rankings

4 hedge funds and large institutions have $1K invested in Cytori Therapeutics Inc Warrant in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

67% less capital invested

Capital invested by funds: $3K → $1K (-$2K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.36K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$2.02K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1K +$1.36K +176,649 New
SM
2
Sabby Management
Florida
– -$2.02K -262,620 -87%

CYTXW Hedge Fund Activity: Q3 2018 in Review

4 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q3 2018, worth a combined $1K — down 67% from $3K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CYTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.36K. The largest seller was Sabby Management, cutting an estimated $2.02K.

  • 4 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q3 2018, up from 3 in Q2 2018.
  • Funds reported $1K of Cytori Therapeutics Inc Warrant stock for Q3 2018, down 67% quarter-over-quarter.
  • 1 fund opened new Cytori Therapeutics Inc Warrant positions in Q3 2018 and 0 closed out, a net change of +1 holder.
  • The largest Cytori Therapeutics Inc Warrant buyer in Q3 2018 was Susquehanna International Group, an estimated $1.36K added.
  • The largest Cytori Therapeutics Inc Warrant seller in Q3 2018 was Sabby Management, an estimated $2.02K sold.

Based on aggregated 13F filings for Q3 2018.